Maria Grazia Roncarolo's most recent trade in Atara Biotherapeutics Inc was a trade of 150,000 Common Stock done . Disclosure was reported to the exchange on March 31, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Atara Biotherapeutics Inc | Maria Grazia Roncarolo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 150,000 | 238,500 (0%) | 0% | 0 | Common Stock | |
Atara Biotherapeutics Inc | Maria Grazia Roncarolo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 79,500 | 79,500 | - | - | Non-Qualified Stock Option (Right to Buy) | |
Atara Biotherapeutics Inc | Maria Grazia Roncarolo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 57,000 | 88,500 (0%) | 0% | 0 | Common Stock | |
Atara Biotherapeutics Inc | Maria Grazia Roncarolo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 31,500 | 31,500 | - | - | Non-Qualified Stock Option (Right to Buy) | |
Atara Biotherapeutics Inc | Maria Grazia Roncarolo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 20,500 | 31,500 (0%) | 0% | 0 | Common Stock | |
Atara Biotherapeutics Inc | Maria Grazia Roncarolo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 17,500 | 17,500 | - | - | Non-Qualified Stock Option (Right to Buy) | |
Atara Biotherapeutics Inc | Maria Grazia Roncarolo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 11,000 | 11,000 (0%) | 0% | 0 | Common Stock |